Earnings call
Narayana Hrudayalaya Q2 FY26 earnings call: Narayana Hrudayalaya's pure CGHS revenues are expected to increase by INR 2.5 crore per month
By DalalOS Data Desk. Assembled by software from the company's transcript. Not reviewed by a person.
Transcript filed .
The company filed one other transcript for this quarter. This page reads the one with the speakers marked, then the most statements.
Pure CGHS revenues are expected to increase by INR 2.5 crore per month. The new hospital was operational from January 2025, and 90% or a little more of its departments had been commissioned; recently commissioned departments will start ramping up. Camana Bay Hospital's post-commissioning volume increased by 50% in discharges and a little more than 50% in outpatients and daycare compared with pre-commissioning. The company has about 7-8% private mix, compared with Ramsey at 30-32% and other best-in-class peers at 60-70% or higher, including 75% private. The GBP 150 million debt will be serviced by the target.
The numbers management gave
Results
- Camana Bay Hospital's post-commissioning volume increased by 50% in discharges and a little more than 50% in outpatients and daycare compared with pre-commissioning.
Show source
Anesh Shetty: So, between pre- and post-Camana Bay Hospital, just if you look at the volume terms, we're looking at 50% increase in discharges, little more than that in outpatients and daycare, etc. So, we have seen a significant jump post the commissioning.
- The Cayman Islands hospital business has a margin of 43-44% every quarter.
Show source
But just to give you some broader guidance, the hospital does about 43-44%, here and there, in that range every quarter.
- Professional fees to doctors have come to 15.5%.
Show source
That has come to 15.5%.
- The Cayman Islands insurance company was yet to break even or had just slightly broken even this quarter.
Show source
The insurance company is yet to break even or just slightly broken even this quarter.
- The hospital performs robotic surgeries nearly at break-even or sometimes at a loss because the hospital must initially bear doctor-training costs and patients cannot absorb the full cost.
Show source
So, we do those nearly at break-even or sometimes at a loss.
Money and capital
- The GBP 150 million debt will be serviced by the target.
Show source
The GBP 150 million debt will be serviced by the target.
Show 1 more statement
Money and capital
- The new centre caused a one-time loss impact in the current results; excluding it, the business has adequate cash flow to service the debt.
Show source
If you adjust for that, there is adequate cash flow in the business to service.
What it expects ahead
What management expects
- Pure CGHS revenues are expected to increase by INR 2.5 crore per month.
Show source
But for us, for now, the ballpark number is INR 2.5 crore per month increase in pure revenues.
- The increase in revenues from pure CGHS and other schemes may reach INR 30 to 50 crore when all of them come in line, which may happen by Q2 of next year.
Show source
But that is when all of them come in line, and that may happen by say, Q2 of next year.
- The company expects revisions eventually from corporates that follow CGHS.
Show source
But of course, we also expect revisions of these corporates, which also follow CGHS, eventually in the course of time.
- The NHS revenue contracts are long-term evergreen contracts, and management expects no volatility in that revenue base.
Show source
There's no volatility we expected in that revenue base.
- The quarter-on-quarter hospital revenue trend will continue until the new services start growing into a maturity phase. Replaced by a later filing.
Show source
And after that, the quarter-on-quarter trend that we are seeing will continue until these new services start growing into a maturity phase.
What it is building and selling
Projects and capacity
- The new hospital was operational from January 2025, and 90% or a little more of its departments had been commissioned; recently commissioned departments will start ramping up.
Show source
We've commissioned 90% of the departments in the new hospital, or little more than that.
- The company plans to spend about 3000 crores in India over the next three years across Greenfield, Brownfield, O&M and acquisitions.
Show source
But we had guided that over the next three years, we have a plan to spend about 3000 crores in India in a mix of Greenfield, Brownfield, O&M and acquisitions.
Demand and pricing
- The company has about 7-8% private mix, compared with Ramsey at 30-32% and other best-in-class peers at 60-70% or higher, including 75% private.
Show source
That if you look at peers, we are at about 7-8% private mix.
- The company does not take much by way of price increases between quarters.
Show source
Viren Shetty: Between the quarter, we don't take much by way of price increases.
Segments
- International business is primarily Bangladesh, and the company is looking to wind it down over the next couple of years.
Show source
But this is a business we're looking to wind down over the next couple of years.
Deals and partners
- The NHS provides 90-93% of the revenue through contracted long-term secure revenue.
Show source
So, let's look at the absolute base case where the bulk of the revenue, which is 90-93% is contracted long-term secure revenue by the NHS.
Risks, rules and outside factors
Outside factors
- Pure CGHS accounts make up around 60% of the CGHS and other corporate accounts that follow the CGHS rate.
Show source
The CGHS and the few of the other corporates which follow the CGHs rate, I mean, the pure CGHS out of those accounts are around 60%.
Rules and policy
- The CGHS rate revisions have come into force, and Narayana Hrudayalaya expects around 30% benefit on the packages because of the revision.
Show source
What we've seen is that, we expect around 30% benefit on the packages because of this revision.
- The company expects no benefit beyond 12% on the non-packaged part because medicines and consumables make up around 55% of the numbers and are on a cost-to-cost basis.
Show source
But on the non-packaged part, we would not see any benefit beyond 12% because most of the component on the non-packaged part is the medicines consumables, which is around 55% of the numbers.
- The CGHS revision could benefit Narayana Hrudayalaya by around 1% of monthly revenues, with maybe 70 to 80% of that flowing through into EBITDA.
Show source
12 All in all, we could see, because of this improvement, around 1% benefit on the monthly revenues and maybe 70 to 80% of it flowing through into the EBITDA.
Everything else said on the call
Group structure
- The parent entity in the UK made the acquisition and is incurring its transaction costs in the UK books; typical transaction costs are about 5%.
Show source
The typical transaction cost range is about 5%.
- The target's cost structure was priced into the deal, and the company knows those financials.
Show source
Their cost structure is what is already been priced in in the deal; we know those financials.
Other
- The hospital is new and patient flow has not yet been established. Replaced by a later filing.
Show source
So essentially, the hospital is new, and the patient flow has not yet been established.
What the company said on its earnings call, taken from its own transcript. Not advice.
Questions and answers
This transcript does not separate questions and answers, so they are not listed here.
Questions about this call
- When was the Narayana Hrudayalaya Q2 FY26 earnings call transcript filed?
- Narayana Hrudayalaya filed the transcript with the exchange on 24 Nov 2025. This page is built from that transcript.
- What does this page list?
- 25 statements from the transcript across 11 topics, 15 of them with a figure. Each statement is shown with the transcript sentence it came from.
- Are the analysts' questions included?
- No. This transcript does not separate the questions from the answers, so they are not listed. The statements by topic still cover what management said.
- Who wrote this page?
- DalalOS Data Desk. Assembled by software from the company's transcript. Not reviewed by a person. How it is made, and what it leaves out, is on the method page linked from the byline.